What does MAIA Biotechnology, Inc. do?
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer…
What is MAIA Biotechnology, Inc.'s P/E and P/B ratio?
MAIA Biotechnology, Inc. has a P/E ratio of -1.8 and a P/B ratio of 3.37.
What is MAIA Biotechnology, Inc.'s debt-to-equity ratio?
MAIA Biotechnology, Inc. has a debt-to-equity ratio of 0.00.
How much does MAIA Biotechnology, Inc. owe compared with what it owns?
MAIA Biotechnology, Inc. owes $0.27 for every $1 it owns (balance sheet Jun 2026), which is low.
What is MAIA Biotechnology, Inc.'s Positivity rank?
MAIA Biotechnology, Inc. is ranked #2,865 of 6,775 companies globally and #1,025 of 4,000 in United States on PositoAI, with a Positivity Score of 21,116.
Does MAIA Biotechnology, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for MAIA Biotechnology, Inc..
Where can I read the latest news about MAIA Biotechnology, Inc.?
Recent headlines about MAIA Biotechnology, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does MAIA Biotechnology, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of MAIA Biotechnology, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.